Short-term Effects of Ventilation Tubes in Children With Chronic Otitis Media With Effusion
1 other identifier
interventional
60
1 country
2
Brief Summary
The goal of this clinical, randomized trial is to compare the sleeping patterns and quality of life of children with chronic otitis media with effusion (OME) with or without tympanic tubes insertion. The main questions it aims to answer are:
- Does tympanic tube insertion have an effect on sleep quality in children with chronic OME?
- Does tympanic tube insertion improve the quality of life for the children with chronic OME and their caregivers? Participants will have their movements during sleep and number of awakenings measured by an accelerometer placed on their wrist for 7 nights before and after tympanic tube insertion. Their caregivers will answer questionnaires regarding quality of life on behalf of the child. Researchers will compare with a control group of children who also is diagnosed with chronic OME. They will also have their sleep monitored for 7 nights and their caregivers will complete quality of life questionnaires, but the will not receive a tympanic tube. However the control group will be reassessed a month after baseline, and if they still qualify for tympanic tube insertion they will undergo the same routine as the intervention group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2017
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 20, 2017
CompletedFirst Submitted
Initial submission to the registry
February 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2022
CompletedFirst Posted
Study publicly available on registry
October 25, 2023
CompletedJanuary 16, 2026
January 1, 2026
5.4 years
February 17, 2017
January 14, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Change in sleep quality
Sleep length and quality. An accelerometer is fitted on the participants and measures movement in 3 axis. The movement counts from the acclerometer will be processed by Sadeh's algorithm giving assessed minutes of total sleep, awakenings and sleep quality. The outcome will be assessed by a blinded investigator.
For the intervention group: 7 nights before and 7 nights after intervention. For the control group: 7 nights at time of inclusion.
Change in Quality of Life
Quality of life quantified by the validated questionnaire OM-6. 7-point Likert scale where 1 is no problem and 7 is extreme problem. The global NRS scales were 10 point scales with o = worst possible QoL and 10 = best possible QoL
At inclusion and up to 2 months follow up
Secondary Outcomes (1)
Use of pain reliever
For the intervention group: 7 nights before and 7 nights after intervention. For the control group: 7 nights at time of inclusion.
Study Arms (2)
Tympanostomy tube
EXPERIMENTALInsertion of tympanostomy tubes after 3 months observation for chronic otitis media with effusion (OME) according to the National guidelines in Denmark. Sleep measurements with accelerometer 7 nights before and 7 nights after intervention. Caregivers report use of paracetamol during nights with sleep measurements.
Control
NO INTERVENTIONNo tympanostomy tube treatment up to 1 month after enrollment in control group. Sleep measurements with accelerometer 7 nights at time of inclusion. Caregivers report use of paracetamol during nights with sleep measurements. After 1 month tympanic tube insertion is allowed if still chronic OME. If tympanostomy tubes are needed the children will undergo same evaluation as the intervention group.
Interventions
Ventilation tube insertion in the tympanic membrane
Eligibility Criteria
You may qualify if:
- Age 1-4 years with chronic otitis media with effusion and subjective hearing loss
- \. time ventilation tube insertion
- ASA group 1 and 2
You may not qualify if:
- Recurrent AOM
- Concomitant adenoidectomy or adenotonsillectomy
- Lip-gum-cleft anomalies or other craniofacial malformations
- Downs syndrome
- Existing sleep apnea
- Asthmatic bronchitis or other chronic lung diseases like CF or other sleep disorders
- ASA \> 2
- Children with hyperkinetic syndrome
- Present breastfeeding during night
- Not fluent in Danish language
- Other systemic diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zealand University Hospitallead
- Danish Medical Associationcollaborator
Study Sites (2)
Ørelægerne Fredericia
Fredericia, 7000, Denmark
Peter Tingsgaard
Slagelse, Denmark
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Preben Homoee, MD
Zealand University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- questionnaires and sleep outcome measures will be assessed by masked person
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 17, 2017
First Posted
October 25, 2023
Study Start
January 20, 2017
Primary Completion
June 30, 2022
Study Completion
August 30, 2022
Last Updated
January 16, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
All results in database will be published anonymously after study termination